Market Overview:
The global diabetes devices and drugs market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in diabetes devices and drugs, and rising awareness about diabetes. The global diabetic devices market is segmented on the basis of type into glucose monitors, insulin pumps, continuous blood glucose monitoring systems (CBGMS), automated external defibrillators (AEDs), and others. The insulin pump segment is expected to grow at the highest CAGR during the forecast period owing to its growing demand for better treatment outcomes for people with diabetes. On the basis of application, the global diabetic devices market is segmented into diagnostic/clinics, ICUs, home healthcare, and others. The diagnostic/clinics segment accounted for the largest share of this market in 2017 owing to rising demand for early diagnosis and treatment of diabetes across regions.
Product Definition:
A diabetes device is a medical device that is used to monitor and manage blood sugar levels in people with diabetes. A diabetes drug is a medication that is used to treat diabetes. Diabetes devices and drugs are important because they help people with diabetes to maintain healthy blood sugar levels and avoid serious health complications.
Diabetes Devices:
Diabetes devices, it's usage and growth factor in Diabetes Devices.
The global diabetes devices, it's usage and growth factor in Diabetes Devices and Drugs market size was valued at USD 25.0 billion in 2014. The increasing prevalence of diabetes due to aging, obesity & changing lifestyle is the prime driver for this industry’s growth over the forecast period.
Diabetes Drugs:
Diabetes drugs and it's usage in diabetes devices and drugs market is expected to grow at a significant rate over the forecast period. The major factor that propels the growth of this market includes aging population, sedentary lifestyle, obesity & overweight along with genetic predisposition. Moreover, other factors such as changing food habits and increasing adoption of unhealthy drinks are also responsible for causing diabetes which will further lead to complications during treatment as well as in future.
Application Insights:
The home healthcare segment dominated the market in 2017 and is expected to witness significant growth over the forecast period. The growing need for effective management of diabetes at home without having to undergo hospitalization or travel is one of the major factors driving this segment. Moreover, increasing awareness about self-management and availability of various products such as insulin pen devices, continuous glucose monitors, blood glucose monitoring systems has contributed to high demand for these products among patients with diabetes.
Diagnostic/clinics was estimated as the largest application segment in 2017 owing to rising prevalence of diabetes coupled with an increase in number of clinical trials using new devices and drugs for diagnosing type 1 and type 2 diabetic patients along with their disease progression stages. Furthermore, a rise in adoption rate amongst individuals suffering from chronic diseases such as cancer or heart disorders requiring long term care is also anticipated to boost market growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of diabetes and rising healthcare expenditure. In addition, favorable reimbursement policies for advanced devices are also expected to drive growth in this region. Asia Pacific is estimated to be the fastest-growing regional market from 2018 to 2030 owing to improving healthcare infrastructure, growing patient awareness levels regarding available treatment options, and availability of effective treatment procedures at affordable costs. Moreover, an increase in foreign direct investment by major multinational players such as Novo Nordisk; Sanofi; Roche Diabetes Care; Abbott Diabetes Care Pvt.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is a growing demand for diabetes devices and drugs to manage the condition effectively.
- Technological advancements: Diabetes devices and drugs are constantly evolving with new technological advancements being made in this field on a regular basis. This has helped to improve their efficacy and safety, thereby driving their demand worldwide.
- Growing awareness about diabetes: There is growing awareness about diabetes among people all over the world due to increased media coverage on this topic as well as campaigns by various health organizations highlighting its dangers if left untreated or unmanaged properly .This has led more people to seek diagnosis and treatment for it, thereby boosting the market for diabetes devices and drugs significantly .
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Devices and Drugs Market Research Report
By Type
Diabetes Devices, Diabetes Drugs
By Application
Diagnostic/Clinics, ICUs, Home Healthcare
By Companies
Medtronic, BD, Johnson & Johnson, Abbott Laboratories, Novo Nordisk, Bristol-Myers Squibb, DexCom, Companion Medical, GlaxoSmithKline, Glenmark Pharmaceuticals, Novartis, Roche, Sanofi, MSD, Astrazeneca, Takeda, North China Pharmaceutical Group Corporation, Huadong Medicine, Dongbao Pharmaceutical, Hisun Pharmacy, KELUN, Ginwa, Tianan Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Devices and Drugs Market Report Segments:
The global Diabetes Devices and Drugs market is segmented on the basis of:
Types
Diabetes Devices, Diabetes Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic/Clinics, ICUs, Home Healthcare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- BD
- Johnson & Johnson
- Abbott Laboratories
- Novo Nordisk
- Bristol-Myers Squibb
- DexCom
- Companion Medical
- GlaxoSmithKline
- Glenmark Pharmaceuticals
- Novartis
- Roche
- Sanofi
- MSD
- Astrazeneca
- Takeda
- North China Pharmaceutical Group Corporation
- Huadong Medicine
- Dongbao Pharmaceutical
- Hisun Pharmacy
- KELUN
- Ginwa
- Tianan Pharmaceutical
Highlights of The Diabetes Devices and Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diabetes Devices
- Diabetes Drugs
- By Application:
- Diagnostic/Clinics
- ICUs
- Home Healthcare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Devices and Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetes devices and drugs are medical devices or medications used to help manage diabetes. Devices may include insulin pumps, blood sugar monitors, and other medical equipment. Drugs may be prescribed by a doctor to help lower blood sugar levels in people with diabetes.
Some of the major companies in the diabetes devices and drugs market are Medtronic, BD, Johnson & Johnson, Abbott Laboratories, Novo Nordisk, Bristol-Myers Squibb, DexCom, Companion Medical, GlaxoSmithKline, Glenmark Pharmaceuticals, Novartis, Roche, Sanofi, MSD, Astrazeneca, Takeda, North China Pharmaceutical Group Corporation, Huadong Medicine, Dongbao Pharmaceutical, Hisun Pharmacy, KELUN, Ginwa, Tianan Pharmaceutical.
The diabetes devices and drugs market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diabetes Devices and Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diabetes Devices and Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diabetes Devices and Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diabetes Devices and Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diabetes Devices and Drugs Market Size & Forecast, 2018-2028
4.5.1 Diabetes Devices and Drugs Market Size and Y-o-Y Growth
4.5.2 Diabetes Devices and Drugs Market Absolute $ Opportunity
Chapter 5 Global Diabetes Devices and Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Diabetes Devices and Drugs Market Size Forecast by Type
5.2.1 Diabetes Devices
5.2.2 Diabetes Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Diabetes Devices and Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Diabetes Devices and Drugs Market Size Forecast by Applications
6.2.1 Diagnostic/Clinics
6.2.2 ICUs
6.2.3 Home Healthcare
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diabetes Devices and Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diabetes Devices and Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Diabetes Devices and Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Diabetes Devices and Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Diabetes Devices and Drugs Market Size Forecast by Type
9.6.1 Diabetes Devices
9.6.2 Diabetes Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Diabetes Devices and Drugs Market Size Forecast by Applications
9.10.1 Diagnostic/Clinics
9.10.2 ICUs
9.10.3 Home Healthcare
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Diabetes Devices and Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Diabetes Devices and Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Diabetes Devices and Drugs Market Size Forecast by Type
10.6.1 Diabetes Devices
10.6.2 Diabetes Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Diabetes Devices and Drugs Market Size Forecast by Applications
10.10.1 Diagnostic/Clinics
10.10.2 ICUs
10.10.3 Home Healthcare
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Diabetes Devices and Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Diabetes Devices and Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Diabetes Devices and Drugs Market Size Forecast by Type
11.6.1 Diabetes Devices
11.6.2 Diabetes Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Diabetes Devices and Drugs Market Size Forecast by Applications
11.10.1 Diagnostic/Clinics
11.10.2 ICUs
11.10.3 Home Healthcare
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Diabetes Devices and Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Diabetes Devices and Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Diabetes Devices and Drugs Market Size Forecast by Type
12.6.1 Diabetes Devices
12.6.2 Diabetes Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Diabetes Devices and Drugs Market Size Forecast by Applications
12.10.1 Diagnostic/Clinics
12.10.2 ICUs
12.10.3 Home Healthcare
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Diabetes Devices and Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Diabetes Devices and Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Diabetes Devices and Drugs Market Size Forecast by Type
13.6.1 Diabetes Devices
13.6.2 Diabetes Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Diabetes Devices and Drugs Market Size Forecast by Applications
13.10.1 Diagnostic/Clinics
13.10.2 ICUs
13.10.3 Home Healthcare
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diabetes Devices and Drugs Market: Competitive Dashboard
14.2 Global Diabetes Devices and Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 BD
14.3.3 Johnson & Johnson
14.3.4 Abbott Laboratories
14.3.5 Novo Nordisk
14.3.6 Bristol-Myers Squibb
14.3.7 DexCom
14.3.8 Companion Medical
14.3.9 GlaxoSmithKline
14.3.10 Glenmark Pharmaceuticals
14.3.11 Novartis
14.3.12 Roche
14.3.13 Sanofi
14.3.14 MSD
14.3.15 Astrazeneca
14.3.16 Takeda
14.3.17 North China Pharmaceutical Group Corporation
14.3.18 Huadong Medicine
14.3.19 Dongbao Pharmaceutical
14.3.20 Hisun Pharmacy
14.3.21 KELUN
14.3.22 Ginwa
14.3.23 Tianan Pharmaceutical
